- Location
Acute Kidney Injury
"-
Guerbet Announced That Novation Has Awarded a New Agreement for Dotarem Injection
Nov 12, 2013Guerbet announced that Novation has awarded a new agreement for Dotarem (gadoterate meglumine) injection. Dotarem injection is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain ...
Tags: Novation, Dotarem injection, Guerbet
-
PLC Systems Has Obtained an Approval From The Japanese Ministry MHLW
Oct 18, 2013PLC Systems, a medical device company, has obtained an approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to initiate a single-arm clinical trial in Japan using its RenalGuard therapy. This approval is based on MHLW's ...
Tags: PLC Systems, Renalguard Therapy
-
PLC Medical Systems Has Been Received The Patent Claims Cover Renalguard Therap in US
Jun 9, 2013PLC Medical Systems has been granted a new method patent by the US Patent and Trademark Office, titled, 'Patient Hydration Method.' The patent claims cover the use of RenalGuard Therapy and the RenalGuard device to protect patients' ...
-
Feasibility Study Reports TF-FA Has Been Deployed in Patients with Aortic Insufficiency
May 27, 2013Helio System (TF-FA), an investigational equipment developed for use with the Sapien XT Transcatheter Heart Valve, has been deployed successfully in four patients during a feasibility trial of its use in patients with high-risk aortic ...
Tags: Aortic Insufficiency, Medicine
-
NGA Is a Novel Biomarker for Diagnosing Acute Kidney Injury (AKI)
Jan 31, 2013NGAL (neutrophil gelatinase-associated lipocalin) is a novel biomarker for diagnosing acute kidney injury (AKI). Its measurement can detect damage within 2 hrs of occurrence and also shows a proportionate response to injury. This enables ...
Tags: Acute Kidney Injury, kidney damage, AKI
-
Argutus Medical Was Chosen as One of Ten Companies to Display Their Latest Product
Dec 20, 2012Argutus Medical was chosen as one of ten companies to display their latest product at the Innovators Place™ during the American Society of Nephrology (ASN) Kidney Week 2012. The scientific exposition, which took place from the 1st ...
Tags: AKI Test, Innovators Place, Argutus Medical
-
Cellaegis Devices Has Obtained Health Canada's ITA to Initiate a Pilot Clinical Trial
Dec 18, 2012CellAegis Devices has obtained Health Canada's investigational testing (ITA) approval to initiate a pilot clinical trial of its noninvasive autoRIC device for remote ischemic conditioning (RIC). The CE-marked device is placed around ...
Tags: Health Canada, ITA, clinical trial, RIC
-
Abbott Has Signed an Agreement
Dec 3, 2012Abbott has signed an agreement to acquire all global rights to develop and commercialize AP214 from Action Pharma. AP214 is a hormone analogue which is being developed to prevent acute kidney injury associated with major cardiac surgery ...
Tags: AP214, Abbott, Action Pharma
-
CE Mark Has Been Won by Astute Acute Kidney Injury Immunoassay Test
Oct 15, 2012Astute Medical has obtained CE mark for a new risk assessment tool, designed for patients with acute kidney injury (AKI). The new immunoassay test, NephroCheck, enables large and small hospital laboratories to use two newly validated ...
Related Products
-
Ngal One Step Test Kit /Renal Marker with Ce
-
Getein 1100 Fluorescence Immuno-Quantitative Analyzer for Ngal and Acute Kidney Injury
-
Getein 1600 Fluorescence Immuno-Quantitative Analyzer for Acute Kidney Injury Disease Test
-
Neutrophil Gelatinase-Associated Lipocalin (NGAL) (human) Elisa Kit Early Diagnosis of Acute Kidney Injury
-
Ngal One Step Test Kit /Renal Marker
